Full metadata
Title
An Empirical Study on the Growth of Small and Medium-Sized Pharmaceutical Enterprises through M&A in China
Description
This thesis starts with an analysis of the current situation of the pharmaceutical industry in China, and discusses the strategic mergers and acquisitions (M&A) by small and medium-sized enterprises (SMEs) in the pharmaceutical industry in China. It elaborates on the rationale for the development of the mergers and acquisitions of the pharmaceutical SMEs. Then a literature review is provided on the causes of corporate mergers and acquisitions such as the economies of scale, synergistic effect, transaction costs, market power, and strategic diversification.Next,the thesis analyzes the underlying rationale for the M&A transactions in the pharmaceutical industry in China, and explores the likely path of successful value creation for pharmaceutical SMEs in China. Specifically, with five in-depth case studies of M&A transactions of pharmaceutical firms, this thesis reveals the critical success factors leading to value creation and growth in the practice of mergers and acquisitions of the pharmaceutical SMEs in China.
Date Created
2015
Contributors
- Zhou, Yan (Author)
- Pei, Ker-Wei (Thesis advisor)
- Chen, Hong (Committee member)
- Shen, Wei (Committee member)
- Arizona State University (Publisher)
Topical Subject
Resource Type
Extent
147 pages
Language
Copyright Statement
In Copyright
Primary Member of
Peer-reviewed
No
Open Access
No
Handle
https://hdl.handle.net/2286/R.I.29799
Level of coding
minimal
Note
Doctoral Dissertation Business Administration 2015
System Created
- 2015-06-01 08:08:00
System Modified
- 2021-08-30 01:29:32
- 3 years ago
Additional Formats